Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy

Clinical trial NCT04650204 · TERMINATED

Trial details

NCT number: NCT04650204
Sponsor: Mayo Clinic
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Intractable Epilepsy Malignant Glioma Seizure Disorder WHO Grade 2 Glioma WHO Grade 3 Glioma

Start date: 2020-12-04
Primary completion: 2023-04-30
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.